UnknownNCT04451902
COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic
Studying Rare skin disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Imagine Institute
- Principal Investigator
- Christine BODEMERHôpital Necker-Enfants Malades
- Enrollment
- 80 target
- Eligibility
- All sexes
- Timeline
- 2020 – 2022
Study locations (13)
- University Hospital Brno - EB Centrum CR Dermatolog, Brno, Czechia
- Hôpital de l'Archet 2 (CHU de Nice), Nice, Alpes-Maritimes, France
- Hôpital de Clocheville (CHRU de Tours), Tours, Indre-et-Loire, France
- Hôpital de Brabois (CHU de Nancy), Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France
- Hôpital Charles Nicolle (CHU de Rouen), Rouen, Seine-Maritime, France
- Hôpital Saint Louis (AP-HP), Paris, Île-de-France Region, France
- Hôpital Necker - Enfants malades (AP-HP), Paris, Île-de-France Region, France
- University Hospital of Erlangen - ZSEER - Zentrum für Seltene Erkrankungen Erlangen, Erlangen, Bavaria, Germany
- Städtisches Klinikum Dessau, Dessau Medical Center, Dessau, Saxony-Anhalt, Germany
- Istituto Dermopatico dell'Immacolata, Rome, Lazio, Italy
- IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Lombardy, Italy
- Azienda USL Toscana Centro, Florence, Tuscany, Italy
- Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, Lithuania
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04451902 on ClinicalTrials.gov